Table III.
Correlations between the expression of different connexions and molecular differentiation markers in primary human AML cells.
| Cx32 | Cx37 | Cx43 | Cx45 | |
|---|---|---|---|---|
| CD11c | 0.388 (−0.166) | 0.504 (−0.129) | 0.128 (0.290) | 0.037 (0.389) |
| CD13 | 0.046 (−0.326) | 0.024 (−0.366) | 0.033 (−0.347) | 0.020 (−0.376) |
| CD14 | 0.984 (0.003) | 0.103 (0.277) | 0.030 (0.362) | 0.005 (0.457) |
| CD15 | 0.938 (0.013) | 0.364 (0.154) | 0.003 (0.482) | 0.001 (0.542) |
| CD33 | 0.951 (0.010) | 0.431 (0.132) | 0.408 (0.138) | 0.130 (0.250) |
| CD34 | 0.258 (−0.188) | 0.498 (−0.133) | 0.437 (−0.130) | 0.180 (−0.222) |
The expression was analysed by flow cytometry for the 38 patients in cohort 1. Spearman’s correlation test was used for the statistical analysis, and the results are presented as the p-value with the corresponding correlation coefficients (ϱ) given in parentheses. Correlations with p<0.05 are marked in bold. AML, acute myeloid leukemia.